Private Equity Ownership of US Opioid Treatment Programs
This cross-sectional study assesses acquisitions of US opioid treatment programs by private equity firms overall and at the zip-code level.
Authors
- David T. Zhu (ORCID: https://orcid.org/0000-0002-0173-495X)
- Zirui Song (ORCID: https://orcid.org/0000-0002-1042-1162)
- Simar S. Bajaj (ORCID: https://orcid.org/0000-0002-8498-9674)
- Christopher Cai (ORCID: https://orcid.org/0000-0002-0567-4691)
- Suhas Gondi (ORCID: https://orcid.org/0000-0003-3048-3472)
- Sneha Kannan
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Pittsburgh (US)
- Palo Alto University (US)
- Virginia Commonwealth University (US)
- Massachusetts General Hospital (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1001/jamapsychiatry.2024.4011
- Citations
- 8
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 3.73